Publications

Home » Publications
Export 13 results:
Filters: Author is Maliki, Ramatou  [Clear All Filters]
2024
Peterson B, Arzika AM, Amza A, Maliki R, Karamba AMankara, Moussa M, Kemago M, Liu Z, Houpt E, Liu J et al..  2024.  Assessment of spillover of antimicrobial resistance to untreated children 7 to 12 years old after mass drug administration of azithromycin for child survival in Niger: a secondary analysis of the MORDOR cluster-randomized trial.. Clin Infect Dis.
O'Brien KS, Arzika AM, Amza A, Maliki R, Aichatou B, Bello IMamane, Beidi D, Galo N, Harouna N, Karamba AM et al..  2024.  Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.. N Engl J Med. 391(8):699-709.
Arzika AM, Abdou A, Maliki R, Beido N, Kadri B, Harouna AN, Galo AN, Alio MK, Lebas E, Oldenburg CE et al..  2024.  Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).. PLoS Med. 21(5):e1004386.
2023
Hazel A, Arzika AM, Abdou A, Lebas E, Porco TC, Maliki R, Doan T, Lietman TM, Keenan JD, Blumberg S.  2023.  Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger.. Am J Trop Med Hyg.
Ousmane S, Kollo IA, Jambou R, Boubacar R, Arzika AM, Maliki R, Amza A, Liu Z, Lebas E, Colby E et al..  2023.  Wastewater-Based Surveillance of Antimicrobial Resistance in Niger: An Exploratory Study.. Am J Trop Med Hyg.
2022
Arzika AM, Maliki R, E Goodhew B, Rogier E, Priest JW, Lebas E, O'Brien KS, Le V, Oldenburg CE, Doan T et al..  2022.  Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger.. Nat Commun. 13(1):976.
2021
O'Brien KS, Arzika AM, Amza A, Maliki R, Ousmane S, Kadri B, Nassirou B, Mankara AKaramba, Harouna ANaser, Colby E et al..  2021.  Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).. BMC Public Health. 21(1):822.
Arzika AM, Maliki R, Abdou A, Mankara AK, Harouna AN, Cook C, Hinterwirth A, Worden L, Zhong L, Chen C et al..  2021.  Gut resistome of preschool children after prolonged mass azithromycin distribution: a cluster-randomized trial.. Clin Infect Dis.
2020
Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E et al..  2020.  Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.. N Engl J Med. 383(20):1941-1950.
Doan T, Hinterwirth A, Worden L, Arzika AM, Maliki R, Chen C, Zhong L, Zhou Z, Acharya NR, Porco TC et al..  2020.  Post-antibiotic Ocular Surface Microbiome in Children: A Cluster-Randomized Trial.. Ophthalmology. 127(8):1127-1130.
2019
Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SElh, Ali MMoussa, Cook C, Lebas E, Lin Y, Ray KJ et al..  2019.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.. N Engl J Med. 380(23):2207-2214.
Doan T, Arzika AM, Hinterwirth A, Maliki R, Zhong L, Cummings S, Sarkar S, Chen C, Porco TC, Keenan JD et al..  2019.  Macrolide Resistance in MORDOR I - A Cluster-Randomized Trial in Niger.. N Engl J Med. 380(23):2271-2273.
2017
Doan T, Arzika AM, Ray KJ, Cotter SY, Kim J, Maliki R, Zhong L, Zhou Z, Porco TC, Vanderschelden B et al..  2017.  Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial.. Clin Infect Dis. 64(9):1147-1153.